Home > Knowledge > Content
Dosage
Sep 20, 2017

Must be under the supervision of doctors with multiple myeloma treatment experience and provide treatment.
If  the patient's neutrophil absolute count (ANC) <1.0 × 10 9 / L, or  the patient's platelet count <50 × 10 9 / L, and its bone marrow  plasma cells accounted for the proportion of nuclear cells <50%, or  patients Of the platelet count <30 × 109 / L,  and its bone marrow plasma cells accounted for 50% of the proportion of  nuclear cells, the FDA should not start the treatment.